European Archives - Page 6 of 1234 - European Medical Journal

Anti-IL-23 Blocks Pathogenic T Cells

Psoriasis affects 60 million people globally. It is an inflammatory skin condition that can significantly impact quality of life…

A Case of Retroperitoneal Leiomyosarcoma of the Inferior Vena Cava

Leiomyosarcoma (LMS) is a malignant neoplasm characterised by smooth muscle differentiation. It is the second most common sarcoma to…

Nivolumab in Patients with Relapsed-Refractory Hodgkin Lymphoma

Up to a quarter of patients with classical Hodgkin’s lymphoma (HL) are resistant or have disease relapse after first-line chemotherapy…

Atypical Postpartum Group A Streptococcal Sepsis with Toxic Shock: Case Report

Sepsis continues to be a significant contributor to maternal mortality, and is responsible for approximately 11% of maternal deaths…

Air Pollution Linked to Elevated Risk of Fatty Liver Disease

Learn how new research links major air pollutants with increased NAFLD risk, urging broader public health focus.

Artificial Sweeteners Linked to Faster Memory Loss and Cognitive Decline

Frequent use of artificial sweeteners may speed up memory loss and thinking decline, particularly for those with diabetes.

Novo Nordisk cuts jobs to fund diabetes and obesity growth

Novo Nordisk announces 9,000 job cuts to streamline operations and reinvest in diabetes and obesity growth, aiming for long-term efficiency.

Study Finds Virtual Rheumatology Care Effective With Low Failure Rates

A study of 226 patients shows virtual rheumatology care is safe and effective, with very low rates of failed visits and no increase in disease-related hospitalizations.

Large Study Finds Fertility Knowledge Gaps in UK Women

A study of nearly 100,000 UK women trying to conceive revealed that 41% could not correctly identify their fertile window, underscoring the urgent need for improved fertility education.

Advancing Ovarian Cancer Care with 3D Micro-Tumour Testing

A recent study introduces an advanced ex vivo 3D micro-tumour testing platform that accurately forecasts individual patient response to chemotherapy, potentially revolutionizing personalized treatment decisions.